Close X
Attorney Spotlight

Find out which two countries Cheryl Palmeri gets the most questions about related to International Trade in today's market? Find out more>


Close X


Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >


Executive Compensation

Effective compensation programs must attract and retain key executives while balancing the interests of employers and equity holders. We work with our clients on a wide range of compensation arrangements in both an ongoing advisory role and in significant corporate events, such as mergers and acquisitions, and initial public offerings. The firm has crafted hundreds of executive pay and board member packages in a climate of changing legal demands and controversy.

In addition, in this era of increasing scrutiny of executive compensation, we advise our public company clients and their compensation committees on a wide array of issues involving executive compensation, including the structure of executive compensation programs, say-on-pay considerations, U.S. Securities and Exchange Commission (SEC) disclosure requirements, proxy statement disclosure, national securities exchange listed company standards, SEC regulatory developments such as those related to pay ratio disclosure and other Dodd-Frank Act requirements, and proxy advisory firm policies.

We provide executive compensation advice to individual executives, boards of directors, management teams, large public companies, private companies of all sizes, private equity and venture capital funds, financial institutions and tax-exempt organizations.

Clients receive counsel, including advice regarding tax considerations, with respect to the design and implementation of compensation arrangements, including the following:

  • Equity incentive plans and awards
  • Executive employment agreements
  • Management incentive compensation programs
  • Supplemental executive retirement plans and other non-qualified deferred compensation plans
  • Director compensation arrangements
  • Severance agreements and policies
  • Clawback policies


View More

Related Experiences

View More

Related Professionals


Viewing 0 of 0 Results

View More


View More

Past Events

View More

Media Mentions

View More




Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.